RP
CMD

Riverbridge Partners’s Cantel Medical Corporation CMD Stock Holding History

Riverbridge Partners’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-77,224
Closed -$2.77M – 152
2020
Q1 		$2.77M Sell
77,224
-225,784
-75% -$12.8M 0.06% 100
2019
Q4 		$21.5M Sell
303,008
-9,917
-3% -$719K 0.39% 80
2019
Q3 		$23.4M Sell
312,925
-5,861
-2% -$497K 0.44% 71
2019
Q2 		$25.7M Sell
318,786
-6,505
-2% -$457K 0.49% 70
2019
Q1 		$21.8M Buy
+325,291
New +$24.6M 0.42% 79

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
LGP
Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Riverbridge Partners's CMD Position: Q2 2020 in Review

Riverbridge Partners sold out of Cantel Medical Corporation (CMD) in Q2 2020, closing a stake of 77,224 shares — an estimated $2.77M sold.

Riverbridge Partners first reported a position in CMD in Q1 2019 and held it in 5 quarters. The position peaked at $25.7M in Q2 2019. 210 funds tracked by Wall St. Rank hold CMD as of Q2 2020.

  • Riverbridge Partners reported no remaining Cantel Medical Corporation position as of Q2 2020 after selling out during the quarter.
  • Riverbridge Partners sold 77,224 Cantel Medical Corporation shares in Q2 2020, an estimated $2.77M.
  • Riverbridge Partners first reported a position in Cantel Medical Corporation in Q1 2019 and held it in 5 quarters.
  • Riverbridge Partners's Cantel Medical Corporation position peaked at $25.7M in Q2 2019.
  • 210 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2020.

Based on Riverbridge Partners's 13F filing for Q2 2020, filed 8 Jul 2020.